Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)
Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus in Prediabetic Patients With Atherosclerotic Cardiovascular Disease
Sponsor: Seung-Whan Lee, M.D., Ph.D.
A PHASE4 clinical study on ASCVD and Pre Diabetes, this trial is ongoing. The trial is conducted by Seung-Whan Lee, M.D., Ph.D. and has accumulated 13 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Feb 2026 — Present [monthly]
Enrolling By Invitation PHASE4
Status: Recruiting → Enrolling By Invitation
-
Sep 2025 — Feb 2026 [monthly]
Recruiting PHASE4
-
Jul 2025 — Sep 2025 [monthly]
Recruiting PHASE4
Phase: NA → PHASE4
-
Feb 2025 — Jul 2025 [monthly]
Recruiting NA
-
Dec 2024 — Feb 2025 [monthly]
Recruiting NA
▶ Show 8 earlier versions
-
Oct 2024 — Dec 2024 [monthly]
Recruiting NA
-
Sep 2024 — Oct 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jan 2024 — Jul 2024 [monthly]
Recruiting NA
-
Jul 2023 — Jan 2024 [monthly]
Recruiting NA
-
May 2023 — Jul 2023 [monthly]
Recruiting NA
-
Apr 2023 — May 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Nov 2022 — Apr 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Seung-Whan Lee, M.D., Ph.D.
- Yuhan Corporation
For direct contact, visit the study record on ClinicalTrials.gov .